Quinalizarin Exerts an Anti-Tumour Effect on Lung Cancer A549 Cells by Modulating the Akt, MAPK, STAT3 and P53 Signalling Pathways

Molecular Medicine Reports - Greece
doi 10.3892/mmr.2017.8110

Related search